Luis Eduardo Pino V (@oxlerceo) 's Twitter Profile
Luis Eduardo Pino V

@oxlerceo

CEO de OxLER, Fundador de AIpocrates. Médico internista, Hematólogo y Oncólogo, BioMolecular, MBA, farmacoeconomía y Postgrado en Inteligencia Artificial ML/DL

ID: 1551686702061731850

linkhttp://www.oxler.info calendar_today25-07-2022 21:52:14

8,8K Tweet

4,4K Followers

1,1K Following

Luis Eduardo Pino V (@oxlerceo) 's Twitter Profile Photo

ADCs/durva/CT in the neoadjuvant treatment of NSCLC, great trial presented by Dr Cascone. Is this the new SOC? #IASLC50 #WCLC2024

ADCs/durva/CT in the neoadjuvant treatment of NSCLC, great trial presented by Dr Cascone. Is this the new SOC? #IASLC50 #WCLC2024